Glucose (Baxter Healthcare Corporation)


Welcome to the PulseAid listing for the Glucose drug offered from Baxter Healthcare Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Baxter Healthcare Corporation
NON-PROPRIETARY NAME: Dextrose Monohydrate
SUBSTANCE NAME: DEXTROSE MONOHYDRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
START MARKETING DATE: 2017-10-05
END MARKETING DATE: 0000-00-00


Glucose HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGlucose from Baxter Healthcare Corporation
LABELER NAME: Baxter Healthcare Corporation
DEA SCHEDULE:
ACTIVE STRENGTH: 2.5(g/50mL)
START MARKETING DATE: 2017-10-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0338-9547_59d635c6-e46a-4f88-b7e9-e197e6790a87
PRODUCT NDC: 0338-9547
APPLICATION NUMBER:

Other DEXTROSE MONOHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
B. Braun Medical Inc.Dextrose
Baxter Healthcare CorporationDEXTROSE
Becton Dickinson and CompanyDextrose
Cardinal HealthDEXTROSE
Fresenius Kabi USA, LLCDextrose
General Injectables & Vaccines, IncDextrose
General Injectables & Vaccines, Inc.Dextrose
Hospira, Inc.Dextrose
International Medication Systems, LimitedDextrose Monohydrate
Physicians Total Care, Inc.Dextrose